Article
Phenotypic screening of cannabinoid receptor 2 ligands shows different sensitivity to genotype.
Biochemical pharmacology - 15 Apr 2017
Hillger Julia M, le Roy Beau, Wang Zi, Mulder-Krieger Thea, Boomsma Dorret I, Slagboom P Eline, Danen Erik H J, IJzerman Adriaan P, Heitman Laura H
Abstract excerpt
The Cannabinoid Receptor 2 (CB2R) is a G protein-coupled receptor (GPCR) investigated intensively as therapeutic target, however no drug has reached the market yet. We investigated personal differences in CB2R drug responses using a label-free whole-cell assay (xCELLigence) combined with cell lines (Lymphoblastoid Cell Lines) from individuals with varying CB2R genotypes. Responses to agonists, partial agonists...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
